The NR4A orphan nuclear receptors do not confer prednisolone resistance in pediatric acute lymphoblastic leukemia

I. M. Ariës; E. S.R. Van Den Dungen; R. Pieters; M. L. Den Boer

doi:10.1038/leu.2013.275

The NR4A orphan nuclear receptors do not confer prednisolone resistance in pediatric acute lymphoblastic leukemia

I. M. Ariës, E. S.R. Van Den Dungen, R. Pieters, M. L. Den Boer

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

1 Citaat (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	422-425
Aantal pagina's	4
Tijdschrift	Leukemia
Volume	28
Nummer van het tijdschrift	2
DOI's	https://doi.org/10.1038/leu.2013.275
Status	Gepubliceerd - feb. 2014
Extern gepubliceerd	Ja

Toegang tot document

10.1038/leu.2013.275

Citeer dit

@article{6a0af86600c64cfcb1c93cb200fc7ac1,

title = "The NR4A orphan nuclear receptors do not confer prednisolone resistance in pediatric acute lymphoblastic leukemia",

keywords = "Animals, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Child, Drug Resistance, Neoplasm/genetics, Gene Knockdown Techniques, Humans, Mice, Nuclear Receptor Subfamily 4, Group A, Member 1/genetics, Nuclear Receptor Subfamily 4, Group A, Member 2/genetics, Nuclear Receptor Subfamily 4, Group A, Member 3/genetics, Orphan Nuclear Receptors/genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Transcriptome",

author = "Ari{\"e}s, {I. M.} and {Van Den Dungen}, {E. S.R.} and R. Pieters and {Den Boer}, {M. L.}",

note = "Funding Information: This work was supported by the Dutch Cancer Society (MLDB, RP, EMCR 2005-3313 and AMC 2008-4265) and NIH grant (MLDB, RP 5R37CA036401). The funding source had no role in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. We acknowledge MWJ Luijendijk (Erasmus MC, Rotterdam, Netherlands) and EF Petricoin (George Mason University, Manassas, USA) for the reverse-phase protein array analysis and IS Jerchel (Erasmus MC, Rotterdam, Netherlands) for her contribution to the lentiviral shRNA knockdown experiments. Professor Dr C de Vries, AMC, The Netherlands, is acknowledged for supplying the Nor1 antibody.",

year = "2014",

month = feb,

doi = "10.1038/leu.2013.275",

language = "English",

volume = "28",

pages = "422--425",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - The NR4A orphan nuclear receptors do not confer prednisolone resistance in pediatric acute lymphoblastic leukemia

AU - Ariës, I. M.

AU - Van Den Dungen, E. S.R.

AU - Pieters, R.

AU - Den Boer, M. L.

N1 - Funding Information: This work was supported by the Dutch Cancer Society (MLDB, RP, EMCR 2005-3313 and AMC 2008-4265) and NIH grant (MLDB, RP 5R37CA036401). The funding source had no role in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. We acknowledge MWJ Luijendijk (Erasmus MC, Rotterdam, Netherlands) and EF Petricoin (George Mason University, Manassas, USA) for the reverse-phase protein array analysis and IS Jerchel (Erasmus MC, Rotterdam, Netherlands) for her contribution to the lentiviral shRNA knockdown experiments. Professor Dr C de Vries, AMC, The Netherlands, is acknowledged for supplying the Nor1 antibody.

PY - 2014/2

Y1 - 2014/2

KW - Animals

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - Child

KW - Drug Resistance, Neoplasm/genetics

KW - Gene Knockdown Techniques

KW - Humans

KW - Mice

KW - Nuclear Receptor Subfamily 4, Group A, Member 1/genetics

KW - Nuclear Receptor Subfamily 4, Group A, Member 2/genetics

KW - Nuclear Receptor Subfamily 4, Group A, Member 3/genetics

KW - Orphan Nuclear Receptors/genetics

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy

KW - Transcriptome

UR - http://www.scopus.com/inward/record.url?scp=84893774526&partnerID=8YFLogxK

U2 - 10.1038/leu.2013.275

DO - 10.1038/leu.2013.275

M3 - Article

C2 - 24056879

SN - 0887-6924

VL - 28

SP - 422

EP - 425

JO - Leukemia

JF - Leukemia

IS - 2

ER -